557 related articles for article (PubMed ID: 35682892)
1. Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies.
Kawahata I; Finkelstein DI; Fukunaga K
Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682892
[TBL] [Abstract][Full Text] [Related]
2. The role of phosphorylation in synucleinopathies: focus on Parkinson's disease.
Cavallarin N; Vicario M; Negro A
CNS Neurol Disord Drug Targets; 2010 Aug; 9(4):471-81. PubMed ID: 20522010
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylated NUB1 distinguishes α-synuclein in Lewy bodies from that in glial cytoplasmic inclusions in multiple system atrophy.
Tanji K; Miki Y; Mori F; Kon T; Kakita A; Takahashi H; Wakabayashi K
Brain Pathol; 2019 Nov; 29(6):803-812. PubMed ID: 31006160
[TBL] [Abstract][Full Text] [Related]
4. Autophagy in Synucleinopathy: The Overwhelmed and Defective Machinery.
Arotcarena ML; Teil M; Dehay B
Cells; 2019 Jun; 8(6):. PubMed ID: 31181865
[TBL] [Abstract][Full Text] [Related]
5. Neuropathology and molecular diagnosis of Synucleinopathies.
Koga S; Sekiya H; Kondru N; Ross OA; Dickson DW
Mol Neurodegener; 2021 Dec; 16(1):83. PubMed ID: 34922583
[TBL] [Abstract][Full Text] [Related]
6. Pathological biochemistry of alpha-synucleinopathy.
Iwatsubo T
Neuropathology; 2007 Oct; 27(5):474-8. PubMed ID: 18018483
[TBL] [Abstract][Full Text] [Related]
7. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
8. Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy.
Schaser AJ; Stackhouse TL; Weston LJ; Kerstein PC; Osterberg VR; López CS; Dickson DW; Luk KC; Meshul CK; Woltjer RL; Unni VK
Acta Neuropathol Commun; 2020 Aug; 8(1):150. PubMed ID: 32859276
[TBL] [Abstract][Full Text] [Related]
9. Involvement of autophagic protein DEF8 in Lewy bodies.
Tanaka MT; Miki Y; Bettencourt C; Ozaki T; Tanji K; Mori F; Kakita A; Wakabayashi K
Biochem Biophys Res Commun; 2022 Oct; 623():170-175. PubMed ID: 35921708
[TBL] [Abstract][Full Text] [Related]
10. Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment.
Poehler AM; Xiang W; Spitzer P; May VE; Meixner H; Rockenstein E; Chutna O; Outeiro TF; Winkler J; Masliah E; Klucken J
Autophagy; 2014; 10(12):2171-92. PubMed ID: 25484190
[TBL] [Abstract][Full Text] [Related]
11. Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology.
Teil M; Dovero S; Bourdenx M; Arotcarena ML; Camus S; Porras G; Thiolat ML; Trigo-Damas I; Perier C; Estrada C; Garcia-Carrillo N; Morari M; Meissner WG; Herrero MT; Vila M; Obeso JA; Bezard E; Dehay B
Brain; 2022 Apr; 145(3):1001-1017. PubMed ID: 35285474
[TBL] [Abstract][Full Text] [Related]
12. Loss of monomeric alpha-synuclein (synucleinopenia) and the origin of Parkinson's disease.
Espay AJ; Lees AJ
Parkinsonism Relat Disord; 2024 May; 122():106077. PubMed ID: 38461037
[TBL] [Abstract][Full Text] [Related]
13. NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy.
Earls RH; Menees KB; Chung J; Gutekunst CA; Lee HJ; Hazim MG; Rada B; Wood LB; Lee JK
Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1762-1771. PubMed ID: 31900358
[TBL] [Abstract][Full Text] [Related]
14. Nilotinib Fails to Prevent Synucleinopathy and Cell Loss in a Mouse Model of Multiple System Atrophy.
Lopez-Cuina M; Guerin PA; Canron MH; Delamarre A; Dehay B; Bezard E; Meissner WG; Fernagut PO
Mov Disord; 2020 Jul; 35(7):1163-1172. PubMed ID: 32291831
[TBL] [Abstract][Full Text] [Related]
15. α-Synuclein and Parkinsonism: Updates and Future Perspectives.
Rosborough K; Patel N; Kalia LV
Curr Neurol Neurosci Rep; 2017 Apr; 17(4):31. PubMed ID: 28324300
[TBL] [Abstract][Full Text] [Related]
16. Neurotoxic conversion of beta-synuclein: a novel approach to generate a transgenic mouse model of synucleinopathies?
Fujita M; Sekigawa A; Sekiyama K; Sugama S; Hashimoto M
J Neurol; 2009 Aug; 256 Suppl 3():286-92. PubMed ID: 19711118
[TBL] [Abstract][Full Text] [Related]
17. Aggregation of alpha-synuclein in the pathogenesis of Parkinson's disease.
Iwatsubo T
J Neurol; 2003 Oct; 250 Suppl 3():III11-4. PubMed ID: 14579119
[TBL] [Abstract][Full Text] [Related]
18. Identification of the sites of tau hyperphosphorylation and activation of tau kinases in synucleinopathies and Alzheimer's diseases.
Duka V; Lee JH; Credle J; Wills J; Oaks A; Smolinsky C; Shah K; Mash DC; Masliah E; Sidhu A
PLoS One; 2013; 8(9):e75025. PubMed ID: 24073234
[TBL] [Abstract][Full Text] [Related]
19. Limelight on alpha-synuclein: pathological and mechanistic implications in neurodegeneration.
Wales P; Pinho R; Lázaro DF; Outeiro TF
J Parkinsons Dis; 2013; 3(4):415-59. PubMed ID: 24270242
[TBL] [Abstract][Full Text] [Related]
20. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
